Bell & Brown Wealth Advisors LLC Sells 250 Shares of Innospec Inc. $IOSP

Bell & Brown Wealth Advisors LLC reduced its holdings in shares of Innospec Inc. (NASDAQ:IOSP) by 4.8% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 4,966 shares of the specialty chemicals company’s stock after selling 250 shares during the period. Bell & Brown Wealth Advisors LLC’s holdings in Innospec were worth $418,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of IOSP. Tsfg LLC acquired a new position in Innospec during the first quarter worth about $35,000. Blue Trust Inc. grew its holdings in shares of Innospec by 38.3% during the 2nd quarter. Blue Trust Inc. now owns 672 shares of the specialty chemicals company’s stock valued at $57,000 after purchasing an additional 186 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in Innospec in the 1st quarter valued at approximately $121,000. Banque Transatlantique SA bought a new position in Innospec in the 1st quarter valued at approximately $196,000. Finally, Baird Financial Group Inc. boosted its position in Innospec by 11.5% in the first quarter. Baird Financial Group Inc. now owns 2,170 shares of the specialty chemicals company’s stock valued at $206,000 after buying an additional 223 shares in the last quarter. 96.64% of the stock is owned by institutional investors and hedge funds.

Innospec Trading Down 0.1%

Shares of IOSP opened at $74.08 on Friday. The stock’s 50-day moving average price is $81.31 and its two-hundred day moving average price is $84.64. Innospec Inc. has a 12 month low of $73.58 and a 12 month high of $128.35. The company has a market capitalization of $1.84 billion, a PE ratio of 94.97 and a beta of 1.04.

Innospec (NASDAQ:IOSP) last issued its quarterly earnings data on Tuesday, August 5th. The specialty chemicals company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.09. The company had revenue of $439.70 million during the quarter, compared to the consensus estimate of $440.70 million. Innospec had a return on equity of 10.89% and a net margin of 1.08%.The firm’s revenue was up 1.1% compared to the same quarter last year. During the same period last year, the company earned $1.39 earnings per share. Equities research analysts predict that Innospec Inc. will post 6.18 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently issued reports on IOSP. Wall Street Zen upgraded shares of Innospec from a “hold” rating to a “buy” rating in a report on Saturday, October 11th. Weiss Ratings upgraded Innospec from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, October 8th. Finally, Zacks Research upgraded Innospec from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. One investment analyst has rated the stock with a Strong Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.